VDJ001 Key Phase III Rare Disease Research Launch

News

Source： Author：

Initiation of the Pivotal Phase III Clinical Trial of VDJ001 for iMCD; Multiple Centers Have Obtained Approval from the Ethics Committee for Drug Clinical Trials, and Peking Union Medical College Hospital Has Launched Patient Recruitment for the Trial.

2026-01-16 87

Previous:Dr. Lu Zhang, Chief Physician of Peking Union Medical College Hospital, was invited to present the Phase II research results of VDJ-001 at the American Society of Hematology Annual Meeting.

Next :Last

Previous Last Back

Relevant information

North Venture Capital leads the C-round financing of Weidejie Biotechnology
Beijing VDJBio Co., LTD. has been selected for the list of 100 new technologies and products
The VDJ-001 clinical research team was invited to give an oral presentation at the EULAR conference
To our original aspiration, embarking on a new journey - Beijing VDJBio Co., LTD.moves into a new ho...
Beijing VDJBio Co., LTD. has been selected as a special board enterprise (regulatory level) by the B...
Weidejie VDJ001 project won the "Top Ten Engineering Practice Cases in the Capital in 2023" award

Stay informed with our latest news, company updates, and industry insights.